IL-17 inhibitors - Novel Drugs Save
Dr. Peter Nash offers his perspective on four new IL17 agents with data presented at the 2025 EULAR meeting in Barcelona, Spain.
Dr. Peter Nash offers his perspective on four new IL17 agents with data presented at the 2025 EULAR meeting in Barcelona, Spain.
By downloading this material, I acknowledge that it may be used only for personal use and personal education and that I will accredit RheumNow.com as the source and owner of this material. Commercial use or mass reproduction of this material without permission from RheumNow (info@rheumnow.com) is prohibited.
If you are a health practitioner, you may Login/Register to comment.
Due to the nature of these comment forums, only health practitioners are allowed to comment at this time.